These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 84300)

  • 21. Peripheral neuropathy in rats fed with clioquinol.
    Jones EL; Searle CE; Smith WT
    J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803
    [No Abstract]   [Full Text] [Related]  

  • 22. Sub-acute myelo-optico neuropathy (a case report).
    Mathew R; Gupta PS
    J Assoc Physicians India; 1978 Jun; 26(6):547-8. PubMed ID: 152755
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neurotoxicity of chinoform].
    Iwashita H
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
    [No Abstract]   [Full Text] [Related]  

  • 24. [The history of quinolines].
    Wolffers I
    Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1246-9. PubMed ID: 3160957
    [No Abstract]   [Full Text] [Related]  

  • 25. Clioquinol.
    Bernard G; Griffith RW
    Lancet; 1977 Apr; 1(8018):956. PubMed ID: 67419
    [No Abstract]   [Full Text] [Related]  

  • 26. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
    Shigematsu I
    Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
    [No Abstract]   [Full Text] [Related]  

  • 27. [A iatrogenic disease... subacute myelo-optico-neuropathy].
    Degos CF; Thomas-Lamotte PJ
    Rev Prat; 1977 Jun; 27(35):2277-85. PubMed ID: 143057
    [No Abstract]   [Full Text] [Related]  

  • 28. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
    Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
    Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
    [No Abstract]   [Full Text] [Related]  

  • 29. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
    Oakley GP
    JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
    [No Abstract]   [Full Text] [Related]  

  • 30. Myelopathy after clioquinol treatment.
    Osterman PO
    Lancet; 1971 Sep; 2(7723):544. PubMed ID: 4105685
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxyquinoline toxicity.
    Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B
    Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067
    [No Abstract]   [Full Text] [Related]  

  • 32. [Case of subacute myelo-optico-neuropathy].
    Mackiewicz J; Wendorff J
    Neurol Neurochir Pol; 1980; 14(1):121-3. PubMed ID: 6445513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subacute myelo-optic neuropathy in Australia.
    Selby G
    Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
    [No Abstract]   [Full Text] [Related]  

  • 34. [Serious sensory-motor neuropathy. A case of renal failure following clioquinol absorption].
    Gendre JP; Barbanel C; Degos JD; Le Quintrec Y
    Nouv Presse Med; 1974 Nov; 3(37):2395-8. PubMed ID: 4282135
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there SMON in India?
    Wadia NH
    Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
    [No Abstract]   [Full Text] [Related]  

  • 36. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
    Bron HL; Korten JJ; Pinckers AJ; Majoor CL
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
    [No Abstract]   [Full Text] [Related]  

  • 37. [Subacute myelo-optic-neuropathy (S.M.O.N.) following treatment with clioquinol (author's transl)].
    Mamoli B; Thaler A; Heilig P; Siakos G
    J Neurol; 1975 Jun; 209(2):139-47. PubMed ID: 51051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurological complications in the course of treatment of acrodermatitis enteropathica with oxyquinoline derivatives].
    Papuziński M; Wilmowska-Pietruszyńska A
    Pediatr Pol; 1974 Nov; 49(11):1393-7. PubMed ID: 4278959
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
    Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
    Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
    [No Abstract]   [Full Text] [Related]  

  • 40. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
    Selby G
    Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.